{"transactions":[{"id":2224985,"issuer":{"id":7653,"kind":"organization","name":"Chemomab Therapeutics Ltd."},"owners":[{"id":125973,"kind":"person","name":"Marvin Donald","position":1,"cik":"0001891264","reported_name":"Marvin Donald","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP, CFO & COO"}}],"security":"Option to Purchase American Depositary Shares","published_at":"2022-06-21T10:01:38.000Z","date":"2021-11-08","kind":"grant","acquired":true,"shares":196875,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options vest and become exercisable over a period of four (4) years, with one quarter (1/4) of the options vesting on November 8, 2022 -- the first anniversary of the grant date -- and the remainder in equal amounts over the ensuing 36 monthly periods, subject to the Reporting Person's continued service."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer."}],"balance_after":196875,"derivative":{"exercise_price":9.77,"expiration_date":"2021-11-08","underlying":"American Depositary Shares","underlying_shares":196875},"source":{"system":"sec-edgar","filing":"0001178913-22-002402","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1534248/000117891322002402/ownership.xml","form_type":"4"}},{"id":2224984,"issuer":{"id":7653,"kind":"organization","name":"Chemomab Therapeutics Ltd."},"owners":[{"id":125973,"kind":"person","name":"Marvin Donald","position":1,"cik":"0001891264","reported_name":"Marvin Donald","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP, CFO & COO"}}],"security":"American Depositary Shares","published_at":"2022-06-21T10:01:38.000Z","date":"2022-03-16","kind":"purchase","acquired":true,"shares":250,"price":3.25,"value":812.5,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer."}],"balance_after":2000,"source":{"system":"sec-edgar","filing":"0001178913-22-002402","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1534248/000117891322002402/ownership.xml","form_type":"4"}},{"id":2224983,"issuer":{"id":7653,"kind":"organization","name":"Chemomab Therapeutics Ltd."},"owners":[{"id":125973,"kind":"person","name":"Marvin Donald","position":1,"cik":"0001891264","reported_name":"Marvin Donald","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP, CFO & COO"}}],"security":"American Depositary Shares","published_at":"2022-06-21T10:01:38.000Z","date":"2022-03-16","kind":"purchase","acquired":true,"shares":250,"price":3.3,"value":825.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer."}],"balance_after":1750,"source":{"system":"sec-edgar","filing":"0001178913-22-002402","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534248/000117891322002402/ownership.xml","form_type":"4"}},{"id":2322836,"issuer":{"id":7653,"kind":"organization","name":"Chemomab Therapeutics Ltd."},"owners":[{"id":125973,"kind":"person","name":"Marvin Donald","position":1,"cik":"0001891264","reported_name":"Marvin Donald","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP, CFO & COO"}}],"security":"Option to Purchase American Depositary Shares","published_at":"2022-03-21T10:02:52.000Z","date":"2021-11-08","kind":"grant","acquired":true,"shares":196875,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options vest and become exercisable over a period of four (4) years, with one quarter (1/4) of the options vesting on November 8, 2022 -- the first anniversary of the grant date -- and the remainder in equal amounts over the ensuing 36 monthly periods, subject to the Reporting Person's continued service."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer."}],"balance_after":196875,"derivative":{"exercise_price":9.77,"expiration_date":"2021-11-08","underlying":"American Depositary Shares","underlying_shares":196875},"source":{"system":"sec-edgar","filing":"0001178913-22-001179","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1534248/000117891322001179/ownership.xml","form_type":"4"}},{"id":2322835,"issuer":{"id":7653,"kind":"organization","name":"Chemomab Therapeutics Ltd."},"owners":[{"id":125973,"kind":"person","name":"Marvin Donald","position":1,"cik":"0001891264","reported_name":"Marvin Donald","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP, CFO & COO"}}],"security":"American Depositary Shares","published_at":"2022-03-21T10:02:52.000Z","date":"2022-03-14","kind":"purchase","acquired":true,"shares":250,"price":4.2,"value":1050.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer."}],"balance_after":1500,"source":{"system":"sec-edgar","filing":"0001178913-22-001179","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1534248/000117891322001179/ownership.xml","form_type":"4"}},{"id":2322834,"issuer":{"id":7653,"kind":"organization","name":"Chemomab Therapeutics Ltd."},"owners":[{"id":125973,"kind":"person","name":"Marvin Donald","position":1,"cik":"0001891264","reported_name":"Marvin Donald","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP, CFO & COO"}}],"security":"American Depositary Shares","published_at":"2022-03-21T10:02:52.000Z","date":"2022-03-14","kind":"purchase","acquired":true,"shares":250,"price":4.1,"value":1025.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer."}],"balance_after":1250,"source":{"system":"sec-edgar","filing":"0001178913-22-001179","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1534248/000117891322001179/ownership.xml","form_type":"4"}},{"id":2322833,"issuer":{"id":7653,"kind":"organization","name":"Chemomab Therapeutics Ltd."},"owners":[{"id":125973,"kind":"person","name":"Marvin Donald","position":1,"cik":"0001891264","reported_name":"Marvin Donald","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP, CFO & COO"}}],"security":"American Depositary Shares","published_at":"2022-03-21T10:02:52.000Z","date":"2022-03-14","kind":"purchase","acquired":true,"shares":250,"price":3.9,"value":975.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer."}],"balance_after":1000,"source":{"system":"sec-edgar","filing":"0001178913-22-001179","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1534248/000117891322001179/ownership.xml","form_type":"4"}},{"id":2322832,"issuer":{"id":7653,"kind":"organization","name":"Chemomab Therapeutics Ltd."},"owners":[{"id":125973,"kind":"person","name":"Marvin Donald","position":1,"cik":"0001891264","reported_name":"Marvin Donald","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP, CFO & COO"}}],"security":"American Depositary Shares","published_at":"2022-03-21T10:02:52.000Z","date":"2022-03-14","kind":"purchase","acquired":true,"shares":250,"price":3.98,"value":995.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer."}],"balance_after":500,"source":{"system":"sec-edgar","filing":"0001178913-22-001179","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1534248/000117891322001179/ownership.xml","form_type":"4"}},{"id":2322831,"issuer":{"id":7653,"kind":"organization","name":"Chemomab Therapeutics Ltd."},"owners":[{"id":125973,"kind":"person","name":"Marvin Donald","position":1,"cik":"0001891264","reported_name":"Marvin Donald","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP, CFO & COO"}}],"security":"American Depositary Shares","published_at":"2022-03-21T10:02:52.000Z","date":"2022-03-14","kind":"purchase","acquired":true,"shares":250,"price":4,"value":1000.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer."}],"balance_after":250,"source":{"system":"sec-edgar","filing":"0001178913-22-001179","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534248/000117891322001179/ownership.xml","form_type":"4"}}]}